GC CELL CORPORATION
Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.
144510 | KO
Overview
Corporate Details
- ISIN(s):
- KR7144510005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 이현로30번길 107, 용인시
- Website:
- http://gccell.com/en/main.do
- Sector:
- Manufacturing
Description
GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-12 00:00 |
주주총회소집공고
|
Korean | 358.9 KB | ||
| 2024-03-12 00:00 |
의결권대리행사권유참고서류
|
Korean | 350.7 KB | ||
| 2024-03-12 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.6 KB | ||
| 2024-02-19 00:00 |
자기주식처분결과보고서
|
Korean | 15.1 KB | ||
| 2024-02-19 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2024-02-08 00:00 |
주주총회소집결의
|
Korean | 14.9 KB | ||
| 2024-02-08 00:00 |
현금ㆍ현물배당결정
|
Korean | 8.5 KB | ||
| 2024-02-08 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 18.7 KB | ||
| 2024-02-08 00:00 |
주식매수선택권부여에관한신고
|
Korean | 12.8 KB | ||
| 2024-02-08 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 25.0 KB | ||
| 2024-01-31 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.5 KB | ||
| 2024-01-31 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2023-12-22 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정)(AB-201의 국내 제 1상 임상시험계획 승인)
|
Korean | 14.4 KB | ||
| 2023-12-22 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정)(AB-201의 호주 제 1상 임상시험계획 승인)
|
Korean | 15.0 KB | ||
| 2023-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GC CELL CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
